North America

Thu
07
Mar

Wana continues focus on industry-leading innovation with Quicksilver Scientific Delivery Systems partnership

Groundbreaking Delivery System will transform the future of cannabis consumption

Wed
06
Mar

Six books to make your cannabis-growing prowess the envy of the at-home crowd

Entering a legal dispensary is an experience for sure, offering as it does convenience, selection and information. But imagine how satisfying it would be to grow and harvest your very own cannabis in your very own home.

Google the words “grow my own weed” and behold the pages upon pages of results. There’s a wealth of information, but plenty of misinformation as well. Plus, the sheer breadth can be overwhelming.

To keep things focused on the very best offerings, The GrowthOp has rounded up six books that will explain how to expertly grow legal cannabis at home, no matter your skill level, and avoid having to dig through mounds of internet garbage.

Wed
06
Mar

What current research tells us about cannabis and autism spectrum disorder

About 1 in 59 children are diagnosed with autism spectrum disorder (ASD), according to data from the CDC. This figure has risen steeply since the 1970s and 1980s when about 1 in every 2,000 children was diagnosed with autism or autism-related disorders. While it remains unclear exactly what these numbers imply, there is hope that cannabis could be an effective treatment option for ASD.

Wed
06
Mar

MedMen claims ignorance of stock promotion

Following the market close on Monday, MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) made a statement claiming it wasn’t aware of stock promotion activity by a company it hired for public relations. Yet in the statement, the company admits “There are statements made which encourage investors to purchase the stock of the Company.”

MedMen acknowledged in the statement that the OTC Markets had made inquiries about promotional activity relating to promotional materials encouraging investors to buy the company’s Class B Subordinate Voting Shares.

Wed
06
Mar

1 hot marijuana stock to buy in March

If you're on the hunt for a great marijuana stock to buy, remember that sometimes taking the road less traveled is the best choice. Big Canadian marijuana producers get the most attention. That makes sense in some ways because of the excitement over the Canadian recreational marijuana market. But smaller marijuana businesses that focus on the U.S. could be even smarter picks.

Wed
06
Mar

This pot stock’s sales were up 870% last quarter!

When it comes to pot stocks, the name of the game is sales growth. With estimates for the industry continuing to get bigger as more countries legalize marijuana, there’s a lot of excitement around cannabis companies and competition is becoming fierce. A good example is Canopy Growth (TSX:WEED)(NYSE:CGC), which has grown by more than 400% in just two years.

Wed
06
Mar

Marijuana study: THC could have more medical value than CBD

Often in the media, general conversations about marijuana’s medicinal benefits reduce the plant’s 100-plus cannabinoids to a focus of one — cannabidiol, or CBD, as it’s commonly referred. CBD is non-psychoactive, presenting an easier entry point for new users while THC includes the intoxicating “high” cannabis is known for. One reductive consensus you might hear is that CBD contains all the good therapeutic value of cannabis, while THC includes virtually known and only benefits those who want to get high.

Wed
06
Mar

More delays in the farce that is International Cannabis Rescheduling

Another day, another abandoned vote in the long-running saga that is reclassification of cannabis by international treaty.

Members of the United Nations’ drug committee have said they will not cast an expected ballot on the recommendations put forward by the World Health Organization (WHO) to loosen the draconian rules on cannabis scheduling.

Wed
06
Mar

Diabetes and marijuana: Here’s what the plant can do to help

The olds among us might remember the French paradox. This was a dieting fad that emerged back in the ’80’s and crested about a decade ago with self-help book whose name falls somewhat short of Gallic sophistication: French Women Don’t Get Fat. The thesis—I’m working from memory here—was something like “We French get to smoke filterless Gauloises, eat double-lobes of foie gras and wheels of triple crème brie, and drink wine with every meal, and you Americans get to have all the heart attacks. Nyah-nyah!” 

But at last America can have its retort: the weed-lovers paradox.

Wed
06
Mar

3 marijuana stocks to avoid like the plague in March

Following a blazing hot January, marijuana stocks cooled a bit in February but still advanced for the month. Through the first two months of 2019, the Horizons Marijuana Life Sciences ETF, which holds around four dozen pot stocks at various weightings, is up 60%.

Wall Street and investors are counting on substantial sales growth in the cannabis industry this year as Canadian adult-use weed legalization ramps up, and new alternatives, such as edibles, infused beverages, and vapes, prepare to hit the market before the one-year anniversary of recreational weed's legalization on Oct. 17.

Pages

Subscribe to RSS - North America